PA8773701A1 - Metodo de separacion y deteccion de acetato de bacedoxifeno en composiciones farmaceuticas - Google Patents

Metodo de separacion y deteccion de acetato de bacedoxifeno en composiciones farmaceuticas

Info

Publication number
PA8773701A1
PA8773701A1 PA20088773701A PA8773701A PA8773701A1 PA 8773701 A1 PA8773701 A1 PA 8773701A1 PA 20088773701 A PA20088773701 A PA 20088773701A PA 8773701 A PA8773701 A PA 8773701A PA 8773701 A1 PA8773701 A1 PA 8773701A1
Authority
PA
Panama
Prior art keywords
acetate
bacedoxifen
pharmaceutical compositions
separation
detection
Prior art date
Application number
PA20088773701A
Other languages
English (en)
Inventor
Tong Wei
E Longfellow Carl
Original Assignee
Wyeth Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wyeth Corp filed Critical Wyeth Corp
Publication of PA8773701A1 publication Critical patent/PA8773701A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D53/00—Separation of gases or vapours; Recovering vapours of volatile solvents from gases; Chemical or biological purification of waste gases, e.g. engine exhaust gases, smoke, fumes, flue gases, aerosols
    • B01D53/34—Chemical or biological purification of waste gases
    • B01D53/92—Chemical or biological purification of waste gases of engine exhaust gases
    • B01D53/94—Chemical or biological purification of waste gases of engine exhaust gases by catalytic processes
    • B01D53/9445—Simultaneously removing carbon monoxide, hydrocarbons or nitrogen oxides making use of three-way catalysts [TWC] or four-way-catalysts [FWC]
    • B01D53/945—Simultaneously removing carbon monoxide, hydrocarbons or nitrogen oxides making use of three-way catalysts [TWC] or four-way-catalysts [FWC] characterised by a specific catalyst
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/12—Radicals substituted by oxygen atoms
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/20—Air quality improvement or preservation, e.g. vehicle emission control or emission reduction by using catalytic converters
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02T—CLIMATE CHANGE MITIGATION TECHNOLOGIES RELATED TO TRANSPORTATION
    • Y02T10/00—Road transport of goods or passengers
    • Y02T10/10—Internal combustion engine [ICE] based vehicles
    • Y02T10/12—Improving ICE efficiencies

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Combustion & Propulsion (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Analytical Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Environmental & Geological Engineering (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Reproductive Health (AREA)
  • Endocrinology (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Analysing Materials By The Use Of Radiation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Steroid Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

SE DESCRIBEN METODOS PARA SEPARAR Y DETECTAR EL ACETATO DE BACEDOXIFENO DE COMPOSICIONES FARMACEUTICAS QUE CONTIENEN UNA MEZCLA DE ACETATO DE BACEDOXIFENO Y UNO O MAS DE OTROS COMPONENTES QUE PRODUCEN PATRONES DE DIFRACCION DE RAYOS X QUE TIENEN PICOS DE INTERFERENCIA EN O CERCA DE LOS PICOS CARACTERISTICOS PARA EL ACETATO DE BACEDOXIFENO.
PA20088773701A 2007-03-30 2008-03-28 Metodo de separacion y deteccion de acetato de bacedoxifeno en composiciones farmaceuticas PA8773701A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US90911307P 2007-03-30 2007-03-30

Publications (1)

Publication Number Publication Date
PA8773701A1 true PA8773701A1 (es) 2008-11-19

Family

ID=39671954

Family Applications (1)

Application Number Title Priority Date Filing Date
PA20088773701A PA8773701A1 (es) 2007-03-30 2008-03-28 Metodo de separacion y deteccion de acetato de bacedoxifeno en composiciones farmaceuticas

Country Status (17)

Country Link
US (1) US20080249303A1 (es)
EP (1) EP2132172A1 (es)
JP (1) JP2010523982A (es)
KR (1) KR20090127431A (es)
CN (1) CN101657421A (es)
AR (1) AR065875A1 (es)
AU (1) AU2008232666A1 (es)
BR (1) BRPI0809950A2 (es)
CA (1) CA2682185A1 (es)
CL (1) CL2008000922A1 (es)
IL (1) IL201043A0 (es)
MX (1) MX2009010508A (es)
PA (1) PA8773701A1 (es)
PE (1) PE20090100A1 (es)
RU (1) RU2009135267A (es)
TW (1) TW200902023A (es)
WO (1) WO2008121800A1 (es)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103534584B (zh) * 2011-05-17 2016-05-04 齐塔库比有限责任公司 使用同步辐射检测多晶型物的方法
CN106198827B (zh) * 2016-08-11 2018-03-27 齐鲁制药有限公司 高效测定醋酸巴多昔芬及其杂质的药物分析方法

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1553781A (en) * 1976-08-05 1979-10-10 Exxon Research Engineering Co Bisphenol derivatives and their use as stabilizers
JPH06104070B2 (ja) * 1985-06-26 1994-12-21 ジ・アップジョン・カンパニ− 形質転換した微生物からのソマトトロピンの精製
US5298397A (en) * 1989-10-19 1994-03-29 Yamasa Shoyu Kabushiki Kaisha Method of assaying d-vanillylmandelic acid
US5998402A (en) * 1996-04-19 1999-12-07 American Home Products Corporation 2-phenyl-1-[4-(2-aminoethoxy)-benzyl]-indoles as estrogenic agents
US6479535B1 (en) * 1998-05-15 2002-11-12 Wyeth 2-phenyl-1-[4-(2-aminoethoxy)-benzyl]-indole and estrogen formulations
US6441144B1 (en) * 1999-05-20 2002-08-27 Alpha Therapeutic Corporation Method for repairing dual virally inactivated immune globulin for intravenous administration
WO2003087796A1 (en) * 2002-04-10 2003-10-23 Bristol-Myers Squibb Company High throughput x-ray diffraction filter sample holder
TW200536845A (en) * 2004-04-07 2005-11-16 Wyeth Corp Crystalline polymorph of bazedoxifene acetate
RU2006132180A (ru) * 2004-04-07 2008-05-20 Вайет (Us) Кристаллический полиморф базедоксифен ацетата
US20070003623A1 (en) * 2005-06-29 2007-01-04 Wyeth Formulations of conjugated estrogens and bazedoxifene

Also Published As

Publication number Publication date
CL2008000922A1 (es) 2009-01-16
EP2132172A1 (en) 2009-12-16
TW200902023A (en) 2009-01-16
PE20090100A1 (es) 2009-02-26
KR20090127431A (ko) 2009-12-11
JP2010523982A (ja) 2010-07-15
BRPI0809950A2 (pt) 2014-10-07
MX2009010508A (es) 2009-10-19
RU2009135267A (ru) 2011-05-10
US20080249303A1 (en) 2008-10-09
CA2682185A1 (en) 2008-10-09
WO2008121800A1 (en) 2008-10-09
AR065875A1 (es) 2009-07-08
AU2008232666A1 (en) 2008-10-09
CN101657421A (zh) 2010-02-24
IL201043A0 (en) 2010-05-17

Similar Documents

Publication Publication Date Title
SG143146A1 (en) Rapid integrity testing of porous materials
CL2008000066A1 (es) Compuestos derivados de (5-hidroxi-3-oxo-2,3-dihidropiridazina-4-carbonil)glicina, inhibidores de hif prolil hidroxilasas; procedimiento de preparacion; composicion farmaceutica que comprende a dichos compuestos; y su uso en el tratamiento de la anem
BRPI0810097A8 (pt) aparelho destinado à separação de uma mistura de fluidos e método de separação de uma mistura de fluidos
CY1110573T1 (el) Απαραβιαστες φαρμακευτικες μορφες δοσολογιας δια του στοματος περιλαμβανουσες ενα οπιουχο αναλγητικο
DK2265156T3 (da) Apparatur og kapsel til fremstilling af en drikkevare
FI20075926A (fi) Menetelmä ja laite plasman tuottamiseksi
EP2123445A4 (en) TRANSPARENT FILM THAT IS WATERPROOFABLE AND METHOD FOR PRODUCING THE SAME
EP2116368A4 (en) TRANSLUCENT GASPERRFILM AND MANUFACTURING METHOD THEREFOR
CL2011001331A1 (es) Clorhidrato de nalmefeno dihidratado; métodos para su preparación; composición farmacéutica que lo comprende; y uso para el tratamiento del alcoholismo.
EP2123446A4 (en) TRANSPARENT GASPERRFILM AND METHOD FOR PRODUCING A TRANSLUCENT GASPERRFILM
DK3431255T3 (da) Fremgangsmåde til langsgående udstrækning af en film i fast tilstand og apparat til at udføre fremgangsmåden
DE112011100359A5 (de) Vorrichtung zum Trennen von miteinander vermischten Stoffen unterschiedlicher Fließfähigkeit
DK2367537T3 (da) Fast sufentanil-lægemiddeldoseringsform omfattende oxygenopfangende midler og fremgangsmåder til anvendelse heraf
CL2012003523A1 (es) Método para la preparación de una composición farmacéutica que contiene un portador de oxígeno termoestable; composicion farmaceutica que contiene un portador de oxigeno altamente purificado y termoestable.
DE602007004702D1 (de) Projektor und Einstellverfahren dafür
DK1953161T3 (da) Nye tricykliske derivater, fremgangsmåde til fremstilling af samme og farmaceutiske sammensætninger indeholdende disse
NI201300106A (es) Composición farmacéutica antihipertensiva
GB201019674D0 (en) Analysis of direct factor Xa Inhibitor
UY34166A (es) Composición farmacéutica oftalmológica tópica que contiene regorafenib
FI20105595A (fi) Laite ja menetelmä virtojen käsittelemiseksi
GB2487130B (en) Bilayer systems including a polydimethylglutarimide-based bottom layer and compositions thereof
CR20160039A (es) Imidazotiazol sulfonamidas como nematicidas
DK2139302T3 (da) Højspændings-Plasmagenereringsapparat
PA8773701A1 (es) Metodo de separacion y deteccion de acetato de bacedoxifeno en composiciones farmaceuticas
DK2245456T3 (da) Fremgangsmåde og sammensætninger til specifik påvisning af fysiologisk acceptable polymermolekyler